SCHEMBL19721579

SCHEMBL19721579

CN1CC2CCC(COC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16316869 0.92 CHRNB2 (0.32)
SCHEMBL20170871 0.83
SCHEMBL6965211 0.78 CHRNB2 (0.33)
SCHEMBL733735 0.78 CHRNB2 (0.33)
SCHEMBL25687521 0.75 JAK2 (0.30)
SCHEMBL21736598 0.75
SCHEMBL4757755 0.73
SCHEMBL19013814 0.73
SCHEMBL19663806 0.73 CHRNB2 (0.35)
SCHEMBL21883665 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596061-B1 COMPOUNDS USEFUL IN THE TREATMENT OR PREVENTION OF A PRMT5-MEDIATED DISORDER ARGONAUT THERAPEUTICS LTD (GB) 2023-09-06 EP disclosed
EP-2630123-B1 SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2017-12-20 EP disclosed